The transaction was completed for an equity value of GBP 239 million, plus an agreed profit ticker from March 31, 2025, until closing, subject to permitted leakages and customary adjustments under the SPA. Shares of Zydus Wellness Ltd ended at ₹2,012.50, down by ₹19.30, or 0.95%, on the BSE.
Zydus Wellness Limited on Friday (August 29) announced that Alidac UK Limited, its wholly owned subsidiary, has acquired Comfort Click Limited (CCL), a UK-based company operating in the vitamins, minerals and supplements (VMS) segment. The acquisition, concluded on August 29, 2025, marks Zydus Wellness’ first overseas acquisition and entry into the VMS category.
Under the share purchase agreement (SPA) signed with the sellers, Alidac acquired 100% of the outstanding ordinary shares of Class A and Class B, 71.43% of non-controlling ordinary shares of Class C, and 66.67% of non-controlling ordinary shares of Class D. As a result, CCL has become a wholly owned subsidiary of Alidac and a step-down subsidiary of Zydus Wellness.
The transaction was completed for an equity value of GBP 239 million, plus an agreed profit ticker from March 31, 2025, until closing, subject to permitted leakages and customary adjustments under the SPA.
Also Read: Zydus Wellness sees shares worth ₹879 crore change hands in block deal window
CCL, headquartered in the UK, operates across the UK and Europe and is expanding its presence in the United States. It reported consolidated revenues of GBP 134 million (unaudited) for the year ended June 30, 2025, with a five-year CAGR of 57% and adjusted operating profit of GBP 21 million. The European VMS market is estimated at GBP 11 billion.
The company owns three brands: WeightWorld offering plant-based supplements, vitamins, collagen, omegas, probiotics, micronutrients and sports nutrition; maxmedix, a specialty gummy brand catering to pediatric nutritional needs; and Animigo, a natural pet VMS brand. A majority of its revenues come from e-commerce and direct-to-consumer (D2C) channels in the UK and Europe.
CCL has been recognised by the Financial Times in 2024 and 2025 as one of the top 1000 fastest-growing companies in Europe. Zydus said the acquisition aligns with its strategy of expanding its international footprint, strengthening consumer health capabilities, and enhancing its presence in digital health and personalised wellness.
Also Read: Zydus Wellness aims for revenue growth in the low teens this year
The acquisition does not fall under related party transactions, and no promoter or group companies have any interest in the deal.
Dr Sharvil Patel, Chairman, Zydus Wellness Limited, “The global acquisition of Comfort Click, a leading player in the digital vitamins, minerals and supplements space, marks a significant step in our journey to empower consumers to make informed choices and embrace wellness-focused products as part of their path to better health."
Shares of Zydus Wellness Ltd ended at ₹2,012.50, down by ₹19.30, or 0.95%, on the BSE.
First Published:
Aug 29, 2025 11:59 PM
IST